Asacol and Isoniazid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Asacol (mesalamine) and Isoniazid (isoniazid). Common drug interactions include arthralgia among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Asacol and Isoniazid. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Asacol?

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 20,618 Asacol users. Check the latest studies of Asacol.

What is Isoniazid?

Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.



On Jul, 13, 2026

29 people who take Asacol and Isoniazid together, and have interactions are studied.

Asacol and Isoniazid drug interactions.

What are the common drug interactions of Asacol and Isoniazid, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Myalgia (muscle pain)
  3. Abdominal pain
  4. Back pain
  5. Mycobacterium tuberculosis complex test positive
  6. Neck pain
  7. Alopecia (absence of hair from areas of the body)
  8. Antinuclear factor positive
  9. Blood creatinine increased
  10. Creatinine renal clearance decreased

male:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Death
  4. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  5. Haematuria (presence of blood in urine)
  6. Injection site erythema (redness at injection site)
  7. Kidney small
  8. Leukocyturia (presence of white blood cells in urine)
  9. Lower limb fracture
  10. Lymphocyte percentage decreased

What are the common drug interactions of Asacol and Isoniazid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Alopecia (absence of hair from areas of the body)

20-29:

  1. Diarrhoea
  2. Dysgeusia (disorder of the sense of taste)
  3. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  4. Hepatitis acute
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Injection site pain

30-39:

  1. Peritoneal tuberculosis

40-49:

  1. Generalised oedema (swelling all over the body)
  2. Haemorrhage subcutaneous (bleeding from skin)
  3. Arthralgia (joint pain)
  4. Renal tubular atrophy (wasting of kidney tubules)
  5. Urinary casts
  6. Antinuclear factor positive
  7. Blood creatinine increased
  8. Blood immunoglobulin g increased
  9. Blood immunoglobulin m increased
  10. Creatinine renal clearance decreased

50-59:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Myalgia (muscle pain)
  4. Mycobacterium tuberculosis complex test positive
  5. Neck pain
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
  8. Anaemia (lack of blood)
  9. Abdominal pain

60+:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Pneumonia
  4. Death
  5. Lower limb fracture
  6. Mycobacterium tuberculosis complex test positive
  7. Palpitations (feelings or sensations that your heart is pounding or racing)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 3 people, 10.34%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.34%
  3. High Blood Pressure: 3 people, 10.34%
  4. Depression: 3 people, 10.34%
  5. Constipation: 3 people, 10.34%
  6. Bowel Movement Irregularity: 3 people, 10.34%
  7. Mycobacterium Tuberculosis Complex Test Positive: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Asacol and Isoniazid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Asacol and Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Asacol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Asacol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isoniazid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and isoniazid (the active ingredients of Asacol and Isoniazid, respectively), and Asacol and Isoniazid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: